Page last updated: 2024-09-05

symmetric dimethylarginine and Polycystic Ovarian Syndrome

symmetric dimethylarginine has been researched along with Polycystic Ovarian Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, WP; Heresztyn, T; Horowitz, JD; Liberts, EA; Marber, MS; Norman, RJ; Rajendran, S; Saha, M; Willoughby, SR1
Barry, JA; Hardiman, PJ; Kay, AR; Lakhani, K; Leiper, J1

Other Studies

2 other study(ies) available for symmetric dimethylarginine and Polycystic Ovarian Syndrome

ArticleYear
Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
    Atherosclerosis, 2009, Volume: 204, Issue:2

    Topics: Adenosine Diphosphate; Adult; Albuterol; Arginine; Body Composition; C-Reactive Protein; Cohort Studies; Endothelial Cells; Endothelium, Vascular; Female; Humans; Inflammation Mediators; Malondialdehyde; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Obesity; Oxidative Stress; Platelet Aggregation; Platelet Function Tests; Polycystic Ovary Syndrome; Stem Cells; Time Factors; Vasodilator Agents

2009
Symmetric dimethylarginine (SDMA) is raised in women with polycystic ovary syndrome: a pilot study.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2011, Volume: 31, Issue:5

    Topics: Adult; Androgens; Anthropometry; Arginine; Case-Control Studies; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Insulin; Kidney; Pilot Projects; Polycystic Ovary Syndrome; Young Adult

2011